Connect with us

Life Sciences

StartUp Health Insights: Perceiv AI Raises $1.5M

StartUp Health Insights: Perceiv AI Raises $1.5M to Better Predict Disease Progression | Week of Dec 13, 2022The StartUp Health portfolio company plans to use the funds to expand their Foresight platform, Perceiv AI’s proprietary AI/ML-driven prognosti…

Published

on

This article was originally published by Stories by StartUp Health on Medium

StartUp Health Insights: Perceiv AI Raises $1.5M to Better Predict Disease Progression | Week of Dec 13, 2022

The StartUp Health portfolio company plans to use the funds to expand their Foresight platform, Perceiv AI’s proprietary AI/ML-driven prognostic platform that predicts disease progression.

Investors, contact us to learn how you can back Health Transformers like the Perceiv AI team.

This week’s announced health innovation funding included $1.5M for Perceiv AI, a Montreal, Québec-based StartUp Health portfolio company on a mission to optimize and de-risk clinical trials for degenerative brain disorders and empower earlier patient diagnoses and interventions in the clinic. The round was composed of strategic and institutional investors from Canada and the US, including CABHI (Centre for Aging + Brain Health Innovation), Plug and Play Ventures, Boreal Ventures, IKJ Capital, Red Abbey Labs, Investissement Québec, and angel investors. <source>

Other recent deals included:

Lokavant, a New York, NY-based clinical trial intelligence company, raised $21M led by Edison Partners, with participation from Roivant Sciences. <source>

Sonde Health, a Boston, MA-based startup developing a voice technology platform to detect various health conditions from biomarkers in a person’s voice, raised $19.25M led by Partners Investment, with participation from KT Corporation, NEOM Company, PureTech Health, and M Ventures. <source>

Ubie, a Tokyo, Japan-based startup providing an AI-powered symptom checker app and hospital SaaS products, raised $19M from Sogo Medical, AAIC Investment, Japan Impact Investment, Rakuten Capital, Shoko Chukin Bank, Japan Finance Corporation, and Mizuho Bank. <source>

Alio, a San Francisco, CA-based remote monitoring system for chronic conditions, raised $18M led by the Widjaja Family Investment Office, with participation from Chase Field and Thomas Krebs. <source>

OMNY Health, an Atlanta, GA-based developer of compliant data and platform solutions for connecting healthcare stakeholders, raised $17M led by Chicago Pacific Founders (CPF). <source>

Cardiosense, a Chicago, IL-based digital health company building an AI platform to detect and manage cardiac disease, raised $15.1M co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations. <source>

Juno Medical, a New York, NY-based tech-enabled healthcare service provider, raised $12M co-led by NEXT VENTURES and Serena Ventures, with participation from Vast Ventures, Empire State Development’s New York Ventures, TXV Partners, Genius Guild, Gaingels, Atento Capital, and Humbition. <source>

Pebble, a Seattle, WA-based company using AI to provide better, smarter, and more comprehensive health benefits plans to startups, raised $12M led by XYZ Venture Capital, with participation from Founders’ Co-op. <source>

Vevo Therapeutics, a San Francisco, CA-based biotechnology company, raised $12M led by Wing Venture Capital and General Catalyst, with participation from Mubadala Capital, AIX Ventures, and Camford Capital. <source>

SaVia Health, a Salt Lake City, UT-based clinical healthcare SaaS company, raised $8.5M led by Intel Capital, with participation from Kickstart, Peterson Ventures, Tom Burton, and Dr. Brent James. <source>

CrowdHealth, an Austin, TX-based company that offers a way to use and pay for healthcare services outside of health insurance, raised $6M led by Next Coast Ventures and Activate Venture Partners. <source>

Turtle Health, a Boston, MA-based virtual fertility counseling clinic, raised $5M from Switch Ventures, Blue Seed Collective, NextGen Venture Partners, Mayo Clinic Ventures, and US Fertility. <source>

WeWALK, a London, UK-based startup developing a “smart cane” for visually impaired people, raised £2M ($2.4M) from Manchester City and İlkay Gündoğan. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Get all our free quarterly reports and sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Passionate about breaking down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

Investors: Contact us to learn how you can invest in Health Transformers and Health Moonshots.

Digital health entrepreneur? Don’t make the journey alone. Learn more about the StartUp Health Community and how StartUp Health invests.

Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.


StartUp Health Insights: Perceiv AI Raises $1.5M was originally published in StartUp Health on Medium, where people are continuing the conversation by highlighting and responding to this story.

therapeutics
biomarkers
medical
healthcare
digital health
ai
hospital
venture capital
fund

Markets

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending